A detailed history of Farther Finance Advisors, LLC transactions in Geron Corp stock. As of the latest transaction made, Farther Finance Advisors, LLC holds 1,186 shares of GERN stock, worth $3,973. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,186
Previous 30 3853.33%
Holding current value
$3,973
Previous $130,000 4045.38%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$4.17 - $4.99 $4,820 - $5,768
1,156 Added 3853.33%
1,186 $5.39 Million
Q4 2023

Feb 14, 2024

BUY
$1.74 - $2.31 $52 - $69
30 New
30 $63,000

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $1.27B
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Farther Finance Advisors, LLC Portfolio

Follow Farther Finance Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Farther Finance Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Farther Finance Advisors, LLC with notifications on news.